Prediabetes management in the Middle East, Africa and Russia: Current status and call for action

Diab Vasc Dis Res. 2019 May;16(3):213-226. doi: 10.1177/1479164118819665. Epub 2019 Jan 3.

Abstract

Most data on the burden of diabetes and prediabetes are from countries where local infrastructure can support reliable estimates of the burden of non-communicable diseases. Countries in the Middle East and Africa, together with Russia, have a total population of almost 2 billion, but have been relatively overlooked by authors in this field. We reviewed the prevalence and drivers of prediabetes and diabetes across this large region. A large, and variable, burden of dysglycaemia exists, especially in Middle Eastern and North African countries, associated with high levels of obesity and sedentariness, with a generally lower prevalence in most other parts of Africa. The design and size of studies are highly variable, and more research to quantify the scale of the problem is needed. Local barriers to care relating to issues concerned with gender, consanguinity, lack of understanding of diabetes, lack of understanding of obesity as a health issue, and limited resource at a national level for tracking and intervention for diabetes and other non-communicable diseases. Lifestyle interventions with proven local cost-effectiveness, enhanced access to pharmacologic intervention, and societal interventions to promote better diet and more activity will be an important element in strategies to combat these adverse trends.

Keywords: Africa; Diabetes; Middle East; Russia; non-diabetic hyperglycaemia; prediabetes.

Publication types

  • Review

MeSH terms

  • Adult
  • Africa / epidemiology
  • Comorbidity
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / therapy*
  • Female
  • Global Health*
  • Health Promotion / organization & administration*
  • Healthy Lifestyle*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Life Style
  • Male
  • Middle Aged
  • Middle East / epidemiology
  • Prediabetic State / diagnosis
  • Prediabetic State / epidemiology
  • Prediabetic State / therapy*
  • Prevalence
  • Prognosis
  • Protective Factors
  • Risk Assessment
  • Risk Factors
  • Risk Reduction Behavior*
  • Russia / epidemiology

Substances

  • Hypoglycemic Agents